A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes
Public ClinicalTrials.gov record NCT02681094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Active-Controlled , Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin 5mg Co-administered With Dapagliflozin 5mg Compared to Saxagliptin 5mg or Dapagliflozin 5mg All Given as Add-on Therapy to Metformin inPatients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Alone
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to evaluate safety and efficacy of therapy with saxagliptin 5mg co-administered with dapagliflozin 5mg, compared to therapy with saxagliptin 5mg or dapagliflozin 5mg in patients who are inadequately controlled on ≥1500mg/day of metformin monotherapy.
Study identification
- NCT ID
- NCT02681094
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 905 participants
Conditions and interventions
Interventions
- Dapagliflozin Drug
- Placebo for Dapagliflozin Drug
- Saxagliptin Drug
- Placebo for Saxagliptin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2016 (Actual)
- Primary completion
- Jul 15, 2017 (Actual)
- Completion
- Jul 15, 2017 (Actual)
- Last update posted
- Oct 10, 2018
2016 – 2017
United States locations
- U.S. sites
- 48
- U.S. states
- 19
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Saraland | Alabama | 36571 | — |
| Research Site | Fresno | California | 93702 | — |
| Research Site | Harbor City | California | 90710 | — |
| Research Site | Hawaiian Gardens | California | 90716 | — |
| Research Site | Lancaster | California | 93534 | — |
| Research Site | Los Angeles | California | 90057 | — |
| Research Site | Montclair | California | 91763 | — |
| Research Site | Pomona | California | 91767 | — |
| Research Site | Spring Valley | California | 91978 | — |
| Research Site | Vallejo | California | 94592 | — |
| Research Site | Denver | Colorado | 80220 | — |
| Research Site | Northglenn | Colorado | 80234 | — |
| Research Site | Wheat Ridge | Colorado | 80033 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Cooper City | Florida | 33024 | — |
| Research Site | Doral | Florida | 33166 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Miami | Florida | 33176 | — |
| Research Site | Miami | Florida | 33186 | — |
| Research Site | Miami Lakes | Florida | 33016 | — |
| Research Site | Buford | Georgia | 30518 | — |
| Research Site | Chicago | Illinois | 60607 | — |
| Research Site | Hazel Crest | Illinois | 60429 | — |
| Research Site | New Orleans | Louisiana | 70115 | — |
| Research Site | Zachary | Louisiana | 70791 | — |
| Research Site | Biloxi | Mississippi | 39531 | — |
| Research Site | Florissant | Missouri | 63031 | — |
| Research Site | Albany | New York | 12203 | — |
| Research Site | The Bronx | New York | 10459 | — |
| Research Site | Asheville | North Carolina | 28801 | — |
| Research Site | Mooresville | North Carolina | 28117 | — |
| Research Site | Fargo | North Dakota | 58103 | — |
| Research Site | Columbus | Ohio | 43201 | — |
| Research Site | Maumee | Ohio | 43537 | — |
| Research Site | East Providence | Rhode Island | 02914 | — |
| Research Site | West Columbia | South Carolina | 29169 | — |
| Research Site | Dallas | Texas | 75208 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | El Paso | Texas | 79935 | — |
| Research Site | Fort Worth | Texas | 76132 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | Houston | Texas | 77036 | — |
| Research Site | Houston | Texas | 77040 | — |
| Research Site | Odessa | Texas | 79761 | — |
| Research Site | Sugar Land | Texas | 77479 | — |
| Research Site | Waco | Texas | 76710 | — |
| Research Site | Salt Lake City | Utah | 84102 | — |
| Research Site | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02681094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02681094 live on ClinicalTrials.gov.